Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Umgangatho ophezulu
Ukubonelela ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leMichiza: Ethyl Nipecotate
CAS: 5006-62-2
Umgangatho ophezulu, iMveliso yoRhwebo
Igama leMchiza | Ethyl Nipecotate |
Izithethantonye | I-Ethyl 3-Piperidinecarboxylate;I-Ethyl piperidine-3-carboxylate;3-Piperidinecarboxylic Acid Ethyl Ester |
Inombolo yeCAS | 5006-62-2 |
Inombolo yeCAT | RF-PI271 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C8H15NO2 |
Ubunzima beMolekyuli | 157.21 |
Indawo yokunyibilika | 165.0 ~ 167.0℃ |
Indawo yokubilisa | 102-104℃ /7 mmHg (lit.) |
Ukuxinana | 1.012 g/mL ku-25℃ (lit.) |
Refractive Index | n20/D 1.460 (lit.) |
Ukunyibilika kwamanzi | I-Miscible |
Imeko yokuthumela ngenqanawa | Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | AbunaMbala ukuya kuLulwelo oluMthubi |
Amanzi | ≤0.50% |
Ukungacoceki Okukodwa | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.0% |
Iintsimbi ezinzima | ≤20ppm |
Isivavanyi | ≥99.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, umgqomo, 25kg / umphanda, okanye ngokwemfuno umthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Ethyl Nipecotate (i-CAS: i-5006-62-2) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient (API) synthesis.
Isicelo se-Ethyl Nipecotate (CAS: 5006-62-2) isetyenziswe kwi-synthesis ye: α, α′-bis [3- (N, N-diethylcarbamoyl) -piperidino] -p-xylene;I-2-amino-4-thiazolyl evela kwi-3-(iso-propyl-3-piperidinyl) phenol;
I-Reactant kwi-synthesis ye: Squalene synthase inhibitors;I-4-aminomethyl-7,8-dihydroxycoumarines kunye ne-ether derivatives yazo yesithsaba;I-Spiroimidazolidinone NPC1L1 inhibitors;Iimodyuli zokubona ikhoram;I-serotonin ekhethiweyo ye-5-HT6 i-receptor antagonists;I-Oxazolidinone RNA-i-agent ezibophezelayo.